» Articles » PMID: 35710910

Metabolic Risk Assessment in Children and Adolescents Using the Tri-ponderal Mass Index

Overview
Journal Sci Rep
Specialty Science
Date 2022 Jun 17
PMID 35710910
Authors
Affiliations
Soon will be listed here.
Abstract

We assessed the risk of metabolic syndrome in children and adolescents who were classified using the tri-ponderal mass index (TMI) with data from the Korea National Health and Nutrition Examination Survey (KNHANES). Data from 10 to 18-year-old subjects that were overweight or obese (n = 1362) were extracted from the KNHANES 2007-2018. Weight classifications were determined by TMI and included overweight and Class I, Class II, and Class III obesity. The standard deviation scores (SDS) of weight, waist circumference, and body mass index (BMI) as well as cardiometabolic risk factors, including blood pressure, serum glucose levels, total cholesterol (T-C), triglycerides, HDL-c, and low-density lipoprotein cholesterol (LDL-c), worsened with the severity of obesity. Most risk factors showed a linear association with the severity increase, except for fasting glucose levels, T-C, and LDL-c. The prevalence of cardiometabolic risks also increased with the severity of obesity, which developed earlier in boys than in girls. The risk of metabolic syndrome significantly increased with the severity of obesity in both unadjusted and adjusted analyses. TMI reflected the severity of obesity and predicted the risk of metabolic syndrome and its components. Therefore, clinical applications of TMI could be a useful to identify the incidence of childhood obesity and metabolic syndromes.

References
1.
Cole T . Weight/heightp compared to weight/height2 for assessing adiposity in childhood: influence of age and bone age on p during puberty. Ann Hum Biol. 1986; 13(5):433-51. DOI: 10.1080/03014468600008621. View

2.
Barstad L, Juliusson P, Johnson L, Hertel J, Lekhal S, Hjelmesaeth J . Gender-related differences in cardiometabolic risk factors and lifestyle behaviors in treatment-seeking adolescents with severe obesity. BMC Pediatr. 2018; 18(1):61. PMC: 5813385. DOI: 10.1186/s12887-018-1057-3. View

3.
FRIEDEWALD W, Levy R, Fredrickson D . Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18(6):499-502. View

4.
Weiss R, Dziura J, Burgert T, Tamborlane W, Taksali S, Yeckel C . Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 2004; 350(23):2362-74. DOI: 10.1056/NEJMoa031049. View

5.
Abdullah A, Stoelwinder J, Shortreed S, Wolfe R, Stevenson C, Walls H . The duration of obesity and the risk of type 2 diabetes. Public Health Nutr. 2010; 14(1):119-26. DOI: 10.1017/S1368980010001813. View